Jose Ruiz
Psychiatry · Orlando, FLNPI 1285739060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2022 is the largest year on record at $1,113, 2.6 times the $434 reported in 2019.
Across 102 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$376
- AbbVie$355
- Otsuka America Pharmaceutical, Inc.$299
- Alkermes, Inc.$228
- Takeda Pharmaceuticals U.S.A., Inc.$155
- Johnson & Johnson$120
- plus $420 from 14 others
What the payments were for
- Food & beverage$1,952100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 4 | $376 |
| AbbVie(2 entities) | 26 | $355 |
| Otsuka America Pharmaceutical, Inc. | 17 | $299 |
| Alkermes, Inc. | 12 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $155 |
| Johnson & Johnson | 8 | $120 |
| Ironshore Pharmaceuticals Inc. | 4 | $71 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| Corium, LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 3 | $33 |
| Lundbeck LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Neos Therapeutics, LP | 1 | $15 |
| Tris Pharma Inc | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,952 in reported general payments places this provider in the 70th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $765 |
| Fluoxetine Hcl | 35 | $465 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 43 | $434 |
| Aripiprazole | 38 | $409 |
| Bupropion XlBupropion Hcl | 20 | $341 |
| Clonazepam | 49 | $270 |
| Sertraline Hcl | 21 | $175 |
| Trazodone Hcl | 21 | $167 |
| Quetiapine Fumarate | 13 | $162 |
| Duloxetine Hcl | 14 | $139 |
| Risperidone | 11 | $137 |
| Hydroxyzine Hcl | 15 | $111 |
| Alprazolam | 12 | $40 |
| Lorazepam | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Orlando
- Ramon MartinezOrlando$354K
- David MedinaOrlando$199K
- Carlos RuizOrlando$104K
- Morteza NadjafiOrlando$58K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.